July 7, 2017

AngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results

ALBANY, N.Y., July 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 fourth quarter and full-year ended May 31, 2017, on Tuesday, July 18, 2017, before the open of the U.S. financial markets.

Management will host a conference call and webcast beginning at 8:00am E.T. on July 18 to discuss the results from the fiscal 2017 fourth quarter and full year and answer questions. To participate in the live call by telephone, please call 877-741-4245 and reference the Conference ID: 4766775.

A live webcast and subsequent archived replay of the conference call may be accessed via the investor relations section of the Company's website under "Events & Presentations" at investors.angiodynamics.com/events. To listen to the live webcast, please go to the website 15-minutes prior to its start to register, download and install the necessary audio software.

About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. More information is available at AngioDynamics.com.

AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.

Company Contact:

AngioDynamics Inc.

Caitlin Stefanik

(518) 795-1418


Investor Relations Contacts:

FTI Consulting

Jim Polson

(312) 553-6730


Kotaro Yoshida

(212) 850-5690


Media Contact:

FTI Consulting

Kimberly Ha

(212) 850-5612


Primary Logo

Source: AngioDynamics

News Provided by Acquire Media

Close window | Back to top

Copyright 2018 AngioDynamics